• EE262 Cost-Effectiveness of Modifying Cardiovascular Disease Risk Factors in Qatar Using the Productivity-Adjusted Life Years (PALY) Metric

    Dec 1, 2025, 00:00

  • HTA10 A New Approach for Modeling the Complexity of the Impact of Caring Using the Family and Caregiving Effects

    Dec 1, 2025, 00:00

  • EE245 Cost-Effectiveness of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective

    Dec 1, 2025, 00:00

  • CO211 Reducing Premature Cancer Mortality Through Early Stage Treatment: A Markov Model Analysis of Pembrolizumab Across Four Tumor Types

    Dec 1, 2025, 00:00

  • CO23 Association Between Objective Response and Overall Survival in BRAF V600e-Mutant Metastatic Colorectal Cancer: An Analysis of the BEACON CRC Trial

    Dec 1, 2025, 00:00

  • EE644 Reducing the Transmission and Annual Burden of Influenza in the UK With Baloxavir Marboxil: A Cost-Effectiveness Analysis Using Evidence From the CENTERSTONE Trial

    Dec 1, 2025, 00:00

  • HTA268 Patient-Centered PICO Scoping in EU HTA: A Pilot Study for Structured Consensus Building Using a Delphi Panel

    Dec 1, 2025, 00:00

  • RWD23 Association of eGFR Decline and Cardiovascular Outcomes in Chronic Kidney Disease Patients: Feasibility of Frequency Matching Replicating Event-Driven Clinical Trials With Real-World Data Long-Term

    Dec 1, 2025, 00:00

  • HSD49 Evaluation of the Effectiveness of Targeted Radiofrequency Therapy in Impingement Syndrome

    Dec 1, 2025, 00:00

  • PCR136 Improving the Conceptual Coverage of the 15-item Penn Parkinson’s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population

    Dec 1, 2025, 00:00

  • P62 EQ-5D Analysis in a Rare Disease: Utilities Across Disease Stages in Multiple-System Atrophy

    Dec 1, 2025, 00:00

  • RWD39 Comparative Cardiovascular Safety of Romosozumab and Denosumab in Osteoporosis Treatment: A Multinational Real-World Cohort Study

    Dec 1, 2025, 00:00

  • EE227 Cost-Effectiveness as Part of the German AMNOG Process Analyzing the 2025 SVR Proposal and Its Implementation Challenges

    Dec 1, 2025, 00:00

  • PCR140 Integrating Patient-Reported Outcome Measures and Patient Experience Into Health Technology Assessment: A Path Towards Patient-Centered Decision Making

    Dec 1, 2025, 00:00

  • SA93 The Health Economic Case for AI in Radiology: A Systematic Review and Appraisal of Evaluation Quality and Methods

    Dec 1, 2025, 00:00

  • EPH123 Healthcare Resource Utilization and Survival of Patients With HR+/HER2-negative Metastatic Breast Cancer After Treatment With CDK4/6-Inhibitors in Finland

    Dec 1, 2025, 00:00

  • PCR166 Optimizing a New Patient-Reported Outcome Instrument for Proliferative Diabetic Retinopathy: A Psychometric Study

    Dec 1, 2025, 00:00

  • HTA47 Assessment of Severity Modifiers vs. End-of-Life Criteria in Oncology

    Dec 1, 2025, 00:00

  • EPH20 Assessing Pharmaceutical Innovation in Europe: Therapeutic Advances vs. Unmet Public Health Need

    Dec 1, 2025, 00:00

  • HPR100 France and the Challenge of High-Cost Innovative Drug Expenditures in Hospitals

    Dec 1, 2025, 00:00

  • HSD15 Bridging Systemic Access Gaps for Cancer Medicines: A Policy Perspective From the Republic of Moldova

    Dec 1, 2025, 00:00

  • HTA100 Cost-Utility Analysis of Including X-linked Adrenoleukodystrophy in the Spanish Newborn Screening Program

    Dec 1, 2025, 00:00

  • MT29 Mortality and Economic Burden of Revisions After Proximal Femoral Fracture Fixation

    Dec 1, 2025, 00:00

  • PCR122 How Are Clinical Trials for Breast Cancer Treatments Currently Being Designed? A Clinical Trial Database Analysis

    Dec 1, 2025, 00:00

  • HTA297 Shifts in the French HTA Transparency Committee’s Use of Indirect Comparisons: Insights From a Systematic Review of the French Transparency Committee (TC) Opinions

    Dec 1, 2025, 00:00

  • HTA313 The Acceptability of Wearables in Remote Monitoring According to Health Technology Assessment HTA Bodies

    Dec 1, 2025, 00:00

  • PCR9 A Review of Approaches to Select Instruments and Items to Measure Patient Reported Tolerability in Clinical Trials in Oncology

    Dec 1, 2025, 00:00

  • P1 Predicting EQ-5D Index Scores: A Comparison Study of Machine Learning and Statistical Methods on Health Survey for England Data

    Dec 1, 2025, 00:00

  • CO168 Nephrotoxicity of Antisense Oligonucleotide Therapies in Duchenne Muscular Dystrophy: A Warning or a Challenge?

    Dec 1, 2025, 00:00

  • PCR176 Patient Perspectives on Unmet Needs in mCRPC: Emphasizing Improved Quality of Life and Delay in Chemotherapy

    Dec 1, 2025, 00:00

  • EE240 Cost-Effectiveness of Coblation Intracapsular Tonsillectomy in the Management of Sleep-Disordered Breathing and Recurrent Tonsillitis: A Brazilian Perspective

    Dec 1, 2025, 00:00

  • CO136 Impact of Different CV Risk Estimation Methods on Cost-Effectiveness Analysis

    Dec 1, 2025, 00:00

  • PCR132 Impact of Shared Treatment Decision Making Between Physicians and Patients on Treatment Satisfaction in Hypertension

    Dec 1, 2025, 00:00

  • RWD37 Comorbidities As a Risk Predictor of Kidney Disease Progression Among Patients Diagnosed With Chronic Kidney Disease

    Dec 1, 2025, 00:00

  • EPH35 Cardiovascular Event Rate and Mortality Among Primary-Prevention Hypercholesterolemia Patients in Japan

    Dec 1, 2025, 00:00

  • RWD54 Decoding Atorvastatin-Induced Arthritis: A Systems Pharmacology Approach Integrating Pharmacovigilance, Bioinformatics, and Pathway Enrichment

    Dec 1, 2025, 00:00

  • MSR117 High-Fidelity Synthetic Patient Pathway Generation and Validation for NSCLC Using A Tabular Variational Autoencoder (TVAE)

    Dec 1, 2025, 00:00

  • RWD72 Economic Burden of Prostate Cancer Overall and by Stages Based on the French Real-World Nationwide Medico-Administrative Database (SNDS)

    Dec 1, 2025, 00:00

  • HTA251 NICE National Institute for Health and Care Excellence Highly Specialized Technology Evaluations: Use of Pivotal Clinical Trial Outcomes to Inform Relative Treatment Effect and Utilities

    Dec 1, 2025, 00:00

  • HPR96 Fit-for-Purpose Real-World Data: Lessons From FDA QCARD and EMA Data Quality Framework

    Dec 1, 2025, 00:00

  • HPR20 An Analysis of Differences in Patient Access to CGRP Migraine Treatments in the Nordic Region

    Dec 1, 2025, 00:00

  • HTA323 The Landscape of the Use of Artificial Intelligence and Machine Learning (AIMI) Methods in Health Technology Assessment (HTA) Submissions

    Dec 1, 2025, 00:00

  • HTA216 Key Challenges Associated With Recent NICE Appraisals for Oncology Targeted Treatments

    Dec 1, 2025, 00:00

  • HTA294 Role of Technical Engagement in NICE Process Under Proportionate Approach to Technology Appraisals

    Dec 1, 2025, 00:00

  • CO125 Garbage In, Garbage Out: Can AI Reduce the Impact of Human Error in eCOA Localized Text Migration?

    Dec 1, 2025, 00:00

  • HTA186 HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?

    Dec 1, 2025, 00:00

  • EE691 The Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients With Early Breast Cancer

    Dec 1, 2025, 00:00

  • PCR115 Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan

    Dec 1, 2025, 00:00

  • CO204 Real-World Efficacy Outcomes for Patients With Relapsed/Refractory Multiple Myeloma (RRMM) From the Flatiron Health Database

    Dec 1, 2025, 00:00

  • CO224 Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of Immunotherapies for Perioperative Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2025, 00:00

  • EE603 Organizational and Environmental Impact of Switching From Intravenous to Subcutaneous Immune Checkpoint Inhibitors (ICIs) in Fran A Real-World Analysis Using PMSI Data

    Dec 1, 2025, 00:00

  • EE667 Socioeconomic Burden Among Children and Adults With Achondroplasia in Europe and Latin America

    Dec 1, 2025, 00:00

  • CO65 Costs and Consequences of Cardiovascular Toxicity Due to Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia

    Dec 1, 2025, 00:00

  • HPR177 Review of Rare Disease Policy Developments in Europe and Türkiye 2020-2025 in the Context of Innovative Orphan Drugs

    Dec 1, 2025, 00:00

  • PCR40 Caregiver QALYs Deserve Better: Why It's Time for a Methodological Rethink

    Dec 1, 2025, 00:00

  • EE673 Strategies for More Cost-Effective HrHPV Screening: A Simulation Study of Pooled Testing Based on Real-World Data in Low- and Middle-Income Countries

    Dec 1, 2025, 00:00

  • EE136 Comparative Assessment of Health-Related Quality of Life Among the Lebanese Population Pre- and Post-COVID-19 Pandemic

    Dec 1, 2025, 00:00

  • MSR228 Eliciting Health State Preferences With Analytical Hierarchy Process: An Illustration With EQ-5D-5L

    Dec 1, 2025, 00:00

  • CO113 Evolution of MRD in Hemato-Oncology Clinical Development

    Dec 1, 2025, 00:00

  • HPR150 Optimizing Pricing Models for Weight-Based and Multistock-Keeping Unit (SKU) Therapies in the EU4

    Dec 1, 2025, 00:00

  • EE223 Cost-Effectiveness and Budget Impact of High-Dose Trivalent Influenza Vaccine Efluelda® in Older Adults: A Greek Healthcare System Perspective

    Dec 1, 2025, 00:00

  • MSR106 extRpolateS: A Shiny-Based Interactive Platform for Time-to-Event Data Modeling in Health Technology Assessments

    Dec 1, 2025, 00:00

  • EE529 Impact of Dupilumab on Mental Health Service Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study

    Dec 1, 2025, 00:00

  • EE703 The Economic Burden of Parkinson's Disease in the Netherlands: From Societal Impact to Investments in Health Solutions

    Dec 1, 2025, 00:00

  • MSR22 AI-Assisted Time-to-Event Projection: A Case Study and Broader Potential

    Dec 1, 2025, 00:00

  • EE521 How Cost-Effectiveness and Budget Impact Drive Pricing and Reimbursement: Insights From an International Comparative Study

    Dec 1, 2025, 00:00

  • HPR36 Bridging the Access Gap: The Role of Non-Public Access Partnerships for Oncology Treatments in China

    Dec 1, 2025, 00:00

  • EE26 A Nutrient-Dense Formula in Undernourished Children in Indonesia: An Effective Cost-Saving Strategy

    Dec 1, 2025, 00:00

  • MT4 AI-Enabled Wearables for Fitness and Preventive Health

    Dec 1, 2025, 00:00

  • OP10 Global Access Licensing: An Expert Interview Study with Scientists-Inventors and Directors of Technology Transfer Offices Involved in the Development and Commercialization of COVID-19 Vaccines

    Dec 1, 2025, 00:00

  • EPH247 The Incidence, Mortality, and Survival of Malignant Non-Small Cell Lung Cancer (NSCLC) in the United States: A Surveillance Epidemiology and End Results (SEER) 2000-2022 Database Analysis

    Dec 1, 2025, 00:00

  • EE650 Resource Utilization Among Patients With Epidermolysis Bullo Preliminary Findings From Seven European Countries

    Dec 1, 2025, 00:00

  • PCR68 Elevating the Patient Perspective: Quantifying First-Line Preferences in Locally Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Using the Threshold Technique

    Dec 1, 2025, 00:00

  • A4SLR: An Agentic Artificial Intelligence-Assisted Systematic Literature Review Framework to Augment Evidence Synthesis for Health Economics and Outcomes Research and Health Technology Assessment

    Nov 1, 2025, 00:00

  • Development and Use of Cognition Bolt-Ons for the EQ-5D-3L and EQ-5D-5L: A Systematic Review

    Nov 1, 2025, 00:00

  • Author Reply

    Nov 1, 2025, 00:00

  • A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report

    Nov 1, 2025, 00:00

  • Are Generic Preference-Based Measures Valid for Use in Informal Carers? A Psychometric Investigation

    Nov 1, 2025, 00:00

  • Health Economics and Outcomes Research in the New Era of Artificial Intelligence: Catch Me If You Can

    Nov 1, 2025, 00:00

  • How Similar Is Similar Enough? Assessment of Indirect Treatment Comparisons to Support Similarity for National Institute for Health and Care Excellence’s Cost Comparison Route

    Nov 1, 2025, 00:00

  • Generative Artificial Intelligence to Automate the Adaptation of Excel Health Economic Models and Word Technical Reports

    Nov 1, 2025, 00:00

  • An Assessment of the Maturity of Cancer Survival Data Used in Economic Models for the National Institute for Health and Care Excellence’s Single Technology Appraisals

    Nov 1, 2025, 00:00

  • Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review

    Nov 1, 2025, 00:00

  • Reevaluating Artificial Intelligence–Enabled Emergency Care in the National Health Service:  Economic Value, Diagnostic Realities, and Ethical Challenges

    Nov 1, 2025, 00:00

  • Author Reply

    Nov 1, 2025, 00:00

  • Meditation and Mindfulness Practices as Supporting Tools to Mental Health Interventions in the Philippines

    Nov 1, 2025, 00:00

  • Strong Preferences or Simplifying Heuristics? Using Internal Validity Tests and Latent Class Analysis to Better Understand Stated Preference Survey Results. A Case Example in Health Preferences Research

    Nov 1, 2025, 00:00

  • Unravelling Public Preferences for the Use of Artificial Intelligence Mobile Health Applications in Australia

    Nov 1, 2025, 00:00

  • The “Artificial Intelligence Statistician”: Utilizing Generative Artificial Intelligence to Select an Appropriate Model and Execute Network Meta-Analyses

    Nov 1, 2025, 00:00

  • Validating Loon Lens 1.0 for Autonomous Abstract Screening and Confidence-Guided Human-in-the-Loop Workflows in Systematic Reviews

    Nov 1, 2025, 00:00

  • ELEVATE-GenAI: Reporting Guidelines for the Use of Large Language Models in Health Economics and Outcomes Research: An ISPOR Working Group Report

    Nov 1, 2025, 00:00

  • Use of Large Language Models to Extract Cost-Effectiveness Analysis Data: A Case Study

    Nov 1, 2025, 00:00

  • Artificial Intelligence in Health Economics and Outcomes Research: Highlighting the Contributions of Early Career Researchers

    Nov 1, 2025, 00:00

  • Roles of Artificial Intelligence--Based Synthetic Data in Health Economics and Outcomes Research

    Nov 1, 2025, 00:00

  • Table of Contents

    Nov 1, 2025, 00:00

  • Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Trial-Based Economic Evaluation

    Nov 1, 2025, 00:00

  • Who Needs Real Data Anyway? Exploring the Use of Synthetic Data in Economic Evaluations of Health Interventions

    Nov 1, 2025, 00:00

  • Editorial Board

    Oct 29, 2025, 10:30

  • Editorial Board

    Oct 6, 2025, 12:01

  • Assessing the Health-Related Quality of Life of Children With Asthma or Eczema by a Proxy: Does Assessment Perspective Matter?

    Oct 6, 2025, 08:52

  • Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review

    Oct 1, 2025, 00:00

  • Measuring Aversion to Income-Related Health Inequality in Canada: An Equity-Efficiency Trade-Off Experiment

    Oct 1, 2025, 00:00

  • Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States

    Oct 1, 2025, 00:00

  • Head-to-Head Comparisons of the Distributional Characteristics and Measurement Properties of the 3-Level and 5-Level Versions of the EQ-5D-Y: A Systematic Review

    Oct 1, 2025, 00:00

  • Development of the County-Level Social Deprivation Index 2020 and Its Association With Health Outcomes in China

    Oct 1, 2025, 00:00

  • Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics

    Oct 1, 2025, 00:00

  • Extending Multidimensional Thresholding to Include Categorical Attributes

    Oct 1, 2025, 00:00

  • Estimated True Out-of-Pocket Cost Changes From the Inflation Reduction Act on Medicare Part D Beneficiaries With Cancer

    Oct 1, 2025, 00:00

  • Provider Differences in Costs, Utilization, and Quality of Primary Care for Traumatic Brain Injury in the Military

    Oct 1, 2025, 00:00

  • Distributional Cost-Effectiveness Analysis and Health Technology Assessment at NICE

    Oct 1, 2025, 00:00

  • Cost per Opioid-Free Year: A Systematic Review and Summary Analysis

    Oct 1, 2025, 00:00

  • Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare

    Oct 1, 2025, 00:00

  • Meaningful Score Differences and Meaningful Score Regions of the Patient-Reported Outcomes Measurement Information System® Pediatric Asthma Impact Scale

    Oct 1, 2025, 00:00

  • Construction and Validation of a Risk Prediction Model for Prolonged Hospitalization of Very Premature Infants

    Oct 1, 2025, 00:00

  • Table of Contents

    Oct 1, 2025, 00:00

  • Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions

    Oct 1, 2025, 00:00

  • Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel

    Oct 1, 2025, 00:00

  • Using Machine Learning to Match Clients and Therapy Providers: Evaluating Clinical Quality and Cost of Care

    Sep 1, 2025, 00:00

  • Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives

    Sep 1, 2025, 00:00

  • Table of Contents

    Sep 1, 2025, 00:00

  • Quality of Care for Patients With Advanced Illness Scale: Development, Preference Elicitation, and Evaluation of Measurement Properties

    Sep 1, 2025, 00:00

  • Referencing Drug Prices of Other Countries May Not Sustainably Lower Prices in the United States: Lessons From Europe

    Sep 1, 2025, 00:00

  • Stability of Danish Population Health Preferences Over Time

    Sep 1, 2025, 00:00

  • Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations

    Sep 1, 2025, 00:00

  • Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study

    Sep 1, 2025, 00:00

  • Validity and Reliability of the EQ-HWB in Parents of Children With Health Conditions

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • Optimizing Monte Carlo Sampling in Health-Economic Modeling: Underlying Concepts and Parameter Definitions

    Sep 1, 2025, 00:00

  • Value-Based Care: Lessons for the United Kingdom’s National Health Service

    Sep 1, 2025, 00:00

  • The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands

    Sep 1, 2025, 00:00

  • Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study

    Sep 1, 2025, 00:00

  • Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study

    Sep 1, 2025, 00:00

  • Author Reply

    Sep 1, 2025, 00:00

  • Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies

    Sep 1, 2025, 00:00

  • Health State Utilities for Achondroplasia: A Time Trade-Off Study

    Sep 1, 2025, 00:00

  • Utility Studies in Rare Diseases: A Systematic Literature Review

    Sep 1, 2025, 00:00

  • Addressing Limitations in the Cost-Effectiveness Analysis of Digitally Supported Care Management for Dementia Caregivers

    Sep 1, 2025, 00:00

  • Editorial Board

    Aug 26, 2025, 09:11

  • Growing Evidence Base on Condition-Specific Patient-Reported Outcome Measures for Long COVID

    Aug 1, 2025, 00:00

  • Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh ...

    Aug 1, 2025, 00:00

  • A Comparative Study of Health and Well-Being Measures in Ireland Using EQ Health and Wellbeing (EQ-HWB) and its Short Version, EQ-5D-5L, and ICEpop Capability Measure for Adults (ICECAP-A)

    Aug 1, 2025, 00:00

  • Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L

    Aug 1, 2025, 00:00

  • Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges

    Aug 1, 2025, 00:00

  • Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study

    Aug 1, 2025, 00:00

  • The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia

    Aug 1, 2025, 00:00

  • Early Budget Impact Analysis of Artificial Intelligence to Support the Review of Radiographic Examinations for Suspected Fractures in National Health Service Emergency Departments

    Aug 1, 2025, 00:00

  • Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports

    Aug 1, 2025, 00:00

  • A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review

    Aug 1, 2025, 00:00

  • Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases

    Aug 1, 2025, 00:00

  • Realizing the Economic Potential of Meditation and Mindfulness Practices in Mental Health Care

    Aug 1, 2025, 00:00

  • The Burden of Mitochondrial Disease: Healthcare and Societal Costs

    Aug 1, 2025, 00:00

  • The Increasing Use of Clinical Outcome Assessments in US Food and Drug Administration Labels and the German Gemeinsamer Bundesausschuss, National Institute for Health and Care Excellence, and the French Haute Autorité de Santé Assessments F ...

    Aug 1, 2025, 00:00

  • The Value of Hope in Cancer Care: Risk Preference and Heterogeneity in Cancer Patients and the General Public

    Aug 1, 2025, 00:00

  • Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity

    Aug 1, 2025, 00:00

  • An Exploratory Study of Alternative Time Frames and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods

    Aug 1, 2025, 00:00

  • Table of Contents

    Aug 1, 2025, 00:00

  • The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

    Aug 1, 2025, 00:00

  • Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare

    Aug 1, 2025, 00:00

  • Addressing Subgroup-Specific Treatment Effects to Avoid Inefficient Care: The Conflict Between Statistical and Health Economic Analyses

    Aug 1, 2025, 00:00

  • A Systematic Review and Meta-Analysis of Health-State Utility Values for Infectious Diseases With Pandemic Potential and Associated Vaccine Adverse Reactions

    Aug 1, 2025, 00:00

  • Editorial Board

    Jul 31, 2025, 08:55

  • SA17 Assessing the Impact of Frailty on Healthcare Burden Post-Surgery in Head and Neck Cancer Patients

    Jul 14, 2025, 17:02

  • Editorial Board

    Jul 3, 2025, 09:29

  • HSD114 Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions

    Jul 1, 2025, 00:00

  • P31 Using Z Codes to Characterize Health and Social Histories in Commercially Insured Non-Hodgkin Lymphoma Patients: Insights from Real-World Data

    Jul 1, 2025, 00:00

  • CO57 Comparative Clinical Effectiveness of Analgesics for the Treatment of Moderate-to-Severe Acute Pain: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EPH63 Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • EE256 Cost-Utility Analysis of Lorlatinib in First-Line Treatment of adult patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (aNSCLC) in Colombia

    Jul 1, 2025, 00:00

  • HPR137 HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges

    Jul 1, 2025, 00:00

  • RWD114 Real-World Characteristics and Treatment Patterns With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective US Claims Study

    Jul 1, 2025, 00:00

  • MSR47 Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective

    Jul 1, 2025, 00:00

  • HPR46 Gender Differences in Use of Cerebrospinal Fluid Biomarker Test and Positron Emission Tomography for Diagnosing Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Real World Setting

    Jul 1, 2025, 00:00

  • HPR3 Determinants of Clinical Trial Participation in Prostate Cancer Patients: A Nationwide Medicare Analysis

    Jul 1, 2025, 00:00

  • PCR146 Using Machine Learning to Identify Key Predictors of Health-Related Quality of Life in Older Women with Early-Stage Breast Cancer Undergoing Endocrine Therapy

    Jul 1, 2025, 00:00

  • MT42 Bench Study Assessing the Impact of the Next Generation of Vitreoretinal-Cataract System on System Set-Up and Tear-Down Time for Vitreoretinal Surgery

    Jul 1, 2025, 00:00

  • EE314 Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings

    Jul 1, 2025, 00:00

  • MSR48 Discrete-Event Simulation Model Projects Economic Outcomes Associated with Long-Term Clinical Remission in Patients with Severe Asthma Receiving Mepolizumab

    Jul 1, 2025, 00:00

  • EE245 Continuous Avoidance Cost in Biosimilar: A Budget Impact Analysis on the Basis of Clinical Trial Model and RWD in Brazil / LATAM / LMIC

    Jul 1, 2025, 00:00

  • EPH132 Administrative Frequency of Alopecia Areata and Clinical Characteristics in a Colombian HMO: a Real-World Data Characterization For 2015-2023

    Jul 1, 2025, 00:00

  • EPH133 Targeted Literature Review and Qualitative Synthesis of the Burden of Oral Corticosteroid-Related Adverse Events in Autoimmune Conditions

    Jul 1, 2025, 00:00

  • RWD27 COVID Impact on Cardiac Implantable Eletronic Devices Trends in the Brazilian Public Health System: a Joinpoint Regression Analysis

    Jul 1, 2025, 00:00

  • PCR1 Health-Related Quality of Life Research in Jordan: A Systematic Review of Published Studies

    Jul 1, 2025, 00:00

  • P40 Cost-Effectiveness Analysis of Second-Generation Antipsychotic Long-Acting Injectables in Patients with Schizophrenia in the United States

    Jul 1, 2025, 00:00

  • RWD42 Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study

    Jul 1, 2025, 00:00

  • EE471 Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study

    Jul 1, 2025, 00:00

  • CO39 Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review

    Jul 1, 2025, 00:00

  • HTA54 Cost-Effectiveness Analysis of Olaparib and Niraparib With Abiraterone Versus Abiraterone for First-Line Treatment of BRCA Mutated Metastatic Castration-Resistant Prostate Cancer in Taiwan

    Jul 1, 2025, 00:00

  • SA4 Relationship Between Event-Free Survival (EFS) and Overall Survival (OS) in Newly Diagnosed Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)

    Jul 1, 2025, 00:00

  • HPR149 Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs

    Jul 1, 2025, 00:00

  • P43 IPDvariate: Reconstructing Patient Characteristics and Survival Data from Kaplan-Meier Curves for Subgroup Analysis

    Jul 1, 2025, 00:00

  • Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy

    Jul 1, 2025, 00:00

  • HTA81 Development of a Novel Value Framework for Evaluating Population Genomic Programs Using A Mixed Methods Approach

    Jul 1, 2025, 00:00

  • EPH188 Economic Modelling of Myopia Management: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EE233 Cost and Prevalence of Pre-Analytical Errors: A Narrative Review

    Jul 1, 2025, 00:00

  • PCR125 Patients' Experiences With Prescription Opioid Use for Acute and/or Chronic Pain Management: A Qualitative Study

    Jul 1, 2025, 00:00

  • PCR104 A Conceptual Model of Multiple Myeloma Symptoms and Impacts, and A Characterization of Pain Among Patients Living With Relapsed/Refractory Multiple Myeloma

    Jul 1, 2025, 00:00

  • HSD113 Characterization of the Trajectories of Care Post-Liver Transplant Recipients From Virginia Using Real World Data

    Jul 1, 2025, 00:00

  • PCR111 Tracking Patterns in Sleep Disturbances During Flare-Ups in Patients With Atopic Dermatitis: Insights From an App-Based Digital Health Tracking Study

    Jul 1, 2025, 00:00

  • PCR22 Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization

    Jul 1, 2025, 00:00

  • PCR170 Post-DCE Qualitative Interviews: A Novel Method to Understand the Rationale for Stated Preferences - An Example Among Patients and Physicians in Severe Asthma

    Jul 1, 2025, 00:00

  • RWD139 Burden Of Hidradenitis Suppurativa In The Brazilian Private Healthcare System

    Jul 1, 2025, 00:00

  • MSR23 Does Our Instrument Include the Right Response Options? Empirical Evidence to Evaluate Floor and Ceiling Effects for Multi-Item Ordinal Instruments

    Jul 1, 2025, 00:00

  • HSD7 Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023

    Jul 1, 2025, 00:00

  • PT34 Response Performance of General Chinese Children Aged 6-11 to EQ-5D-Y-3L: A Multicenter Study

    Jul 1, 2025, 00:00

  • PCR32 Informal Caregivers' Attitudes Towards Robots in Hungary and Poland

    Jul 1, 2025, 00:00

  • HPR49 Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support

    Jul 1, 2025, 00:00

  • HSD6 The Impact of One-Day Surgery Performance Indicators on Hospital Capacities in Hungary

    Jul 1, 2025, 00:00

  • HSD45 US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice

    Jul 1, 2025, 00:00

  • HPR103 Comparing Medicare Maximum Fair Prices with Other Drug Prices in Other Countries

    Jul 1, 2025, 00:00

  • OP11 Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024

    Jul 1, 2025, 00:00

  • EPH3 Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication

    Jul 1, 2025, 00:00

  • HTA41 Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs

    Jul 1, 2025, 00:00

  • Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report

    Jul 1, 2025, 00:00

  • EPH93 Protocol for a Real-World Retrospective Study on Cardiovascular Outcomes in Japan Comparing Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers

    Jul 1, 2025, 00:00

  • RWD11 Real-World Unmet Needs in Patients With HER2-Negative Advanced Gastric, Gastro-Esophageal or Esophageal Adenocarcinoma Receiving First-Line Treatment Globally

    Jul 1, 2025, 00:00

  • PCR70 The Impact of Information and Under-Information on Quality of Life in People With Polycystic Ovary Syndrome

    Jul 1, 2025, 00:00

  • CO33 Comparison of Suicidal Ideation or Personal History of Self Harm Among Patients with Use of Rexulti and All Antipsychotics

    Jul 1, 2025, 00:00

  • P37 Trial-Based Economic Evaluation of the BrainACT Study: Acceptance and Commitment Therapy for Anxiety and/or Depressive Symptoms After Acquired Brain Injury in the Netherlands

    Jul 1, 2025, 00:00

  • P36 Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma

    Jul 1, 2025, 00:00

  • HPR19 Racial Disparity in Healthcare Expenditure Among Older Adults with Cardiovascular Diseases

    Jul 1, 2025, 00:00

  • HSD107 Individualized Electronic Patient Reported Outcome Measures as a Communication Aid in Outpatient Cardiology Care

    Jul 1, 2025, 00:00

  • HSD31 Identification of Barriers to and Practical Strategies for Increasing Clinical Trial Diversity: A Scoping Review

    Jul 1, 2025, 00:00

  • EE490 Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development

    Jul 1, 2025, 00:00

  • RWD21 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic Triple Negative Breast Cancer (mTNBC)

    Jul 1, 2025, 00:00

  • EPH97 Overall Survival in People Living with HIV, Who Experienced Progressive Multifocal Leukoencephalopathy

    Jul 1, 2025, 00:00

  • P20 The Past, Present, and Future of Demand for Bariatric Surgery in Chile: A Subgroup Analysis for no-income (Group A) FONASA Beneficiaries

    Jul 1, 2025, 00:00

  • HSD34 Telehealth for Disease Management: A Scoping Review of Effectiveness in the Perinatal Period

    Jul 1, 2025, 00:00

  • EE326 A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)

    Jul 1, 2025, 00:00

  • SA2 Assessing the Feasibility of Indirect Comparisons of Vaccines: A Framework for Network Meta-Analysis

    Jul 1, 2025, 00:00

  • CO10 A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States

    Jul 1, 2025, 00:00

  • PCR35 Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • RWD36 Accelerating EHR Insights: NLP-Driven Data Abstraction in Gallbladder Cancer

    Jul 1, 2025, 00:00

  • EE454 Economics of Prostate Cancer in Canada: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR12 Exploring the Equity of Out-of-Pocket Healthcare Expenses and Catastrophic Healthcare Expenditures in Taiwanese Households

    Jul 1, 2025, 00:00

  • EPH71 Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)

    Jul 1, 2025, 00:00

  • HTA40 The Role of Real-World Evidence in Addressing Gaps in Health Technology Assessment in Brazil’s Public Healthcare System

    Jul 1, 2025, 00:00

  • EE464 Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review

    Jul 1, 2025, 00:00

  • MSR129 Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review

    Jul 1, 2025, 00:00

  • EE369 Healthcare Resource Utilization (HCRU), Costs, and Outcomes Among Patients With Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) in the United States: A Retrospective, Real-World Analysis of Administrative Claims Data

    Jul 1, 2025, 00:00

  • SA8 A Comparison of Single-Network and Multi-Site Approaches to Real-World Data Collection

    Jul 1, 2025, 00:00

  • EE373 Utilization of Adalimumab and Infliximab Biologics and Biosimilars in Rheumatoid Arthritis Patients

    Jul 1, 2025, 00:00

  • PCR39 Patient-Centered Research (Patient-Reported Outcomes and Quality of Life Outcomes)

    Jul 1, 2025, 00:00

  • HSD52 Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany

    Jul 1, 2025, 00:00

  • PT28 Evaluation of Measurement Properties of Health Assessment Questionnaire Disability Index (HAQ-DI) among Gout Populations in China

    Jul 1, 2025, 00:00

  • MSR109 Artificial Intelligence Integration in Health Technology Assessments: A Review of Global Policies and Practices

    Jul 1, 2025, 00:00

  • EPH128 Changes in the Prevalence of Pregnancy Complications During the COVID-19 Pandemic: Is Increased Prevalence the New Normal?

    Jul 1, 2025, 00:00

  • HSD27 Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer

    Jul 1, 2025, 00:00

  • MSR44 Going Beyond Excel vs. R: An Introduction To Visual Programming for Health Economics Modelling

    Jul 1, 2025, 00:00

  • MSR34 Development of a Novel Approach to Improve Binary Classification Prediction Tasks When Encountering Time-To-Event Data: Performance Comparison of Three Alternative Approaches To Predict Stimulant Use Disorder Among Persons Authorized ...

    Jul 1, 2025, 00:00

  • MSR106 Breaking Linguistic Barriers: Cross-Language HEOR Evidence Integration Through GenAI

    Jul 1, 2025, 00:00

  • CO73 Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (7.5mg) across 1.5 Years

    Jul 1, 2025, 00:00

  • RWD68 AUVI-Q vs. Other Epinephrine Auto-Injector Prescription Was Associated With Reduced Inpatient Hospitalizations for Anaphylaxis in a US Retrospective Commercial Claims Analysis

    Jul 1, 2025, 00:00

  • MSR132 Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study

    Jul 1, 2025, 00:00

  • MSR87 Using Regression Discontinuity in Time Design for Real-World Comparative Effectiveness: A Case Study for the Second-Line Use of Pembrolizumab in Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • P15 Boosting Predictive Power: Thoughtfully Unleashing the Potential of Machine Learning In Real-World Healthcare Outcome Estimation

    Jul 1, 2025, 00:00

  • HSD17 Co-Design of a Discrete Choice Experiment for Revascularization Decisions in Complex Coronary Heart Disease: Importance of Patient Perspectives

    Jul 1, 2025, 00:00

  • PCR33 Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV

    Jul 1, 2025, 00:00

  • EPH57 Administrative Incidence and Prevalence of Multiple Myeloma Using Administrative Claims Data From a Large Health Maintenance Organization in Colombia, 2015–2023

    Jul 1, 2025, 00:00

  • EE407 The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study

    Jul 1, 2025, 00:00

  • HSD77 Patient and Diagnostic Delay in Patients With Breast or Colorectal Cancer

    Jul 1, 2025, 00:00

  • HTA56 A Targeted Review of the Application of Discrete Event Simulation Modeling in CDA-AMC Assessments

    Jul 1, 2025, 00:00

  • MSR127 The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons

    Jul 1, 2025, 00:00

  • PCR204 Over 30 Years of Discrete Choice Experiment Studies in Health Economics: Systematic Review of Current Practice and Reflections on Evolving Practice

    Jul 1, 2025, 00:00

  • RWD141 Impact of Social Determinants of Health on Severe Maternal Morbidity and Pregnancy Outcomes

    Jul 1, 2025, 00:00

  • EE422 Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PT21 US Commercial Health Plan Coverage of Oncology Therapies: 2017 - 2024

    Jul 1, 2025, 00:00

  • EE238 Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data

    Jul 1, 2025, 00:00

  • PCR95 State of Inclusion of Patient-Centered Endpoints in Duchenne Muscular Dystrophy (DMD) Clinical Trials

    Jul 1, 2025, 00:00

  • HSD81 A Real-World Perspective of Quadruple Treatment Patterns for 1L Multiple Myeloma Patients across North and South America, Europe and Asia

    Jul 1, 2025, 00:00

  • EE313 Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China

    Jul 1, 2025, 00:00

  • OP4 Perception Gap Between Preceptors and Pharmacy Students on Clinical Pharmacy Practice Education (CPPE) in Hospital Pharmacy

    Jul 1, 2025, 00:00

  • HSD35 Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • MSR24 Leveraging Machine Learning to Assess the Association of Rash and Survival in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • PCR142 Utility Over Multiple Health Indexes in Non-Small Cell Lung Cancer: Survey Estimates for Patient-Centered Generalized Risk-Adjusted Cost-Effectiveness (GRACE)

    Jul 1, 2025, 00:00

  • HPR128 Cost of Vaccine Misinformation on the US Healthcare System

    Jul 1, 2025, 00:00

  • HSD48 Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example

    Jul 1, 2025, 00:00

  • RWD41 Shifting Landscapes: Rising Trends in Breast and Colon Cancer Screenings and Diagnoses

    Jul 1, 2025, 00:00

  • CO15 Exploring the Relationship Between Hemoglobin Levels and Clinical Outcomes in Anemic Dialysis-Dependent Chronic Kidney Disease Patients

    Jul 1, 2025, 00:00

  • PCR255 Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value

    Jul 1, 2025, 00:00

  • PCR12 Hemolytic Disease of the Fetus and Newborn (HDFN): A Mixed-Methods Preference Study

    Jul 1, 2025, 00:00

  • CO32 Socioeconomic Status and Anti-obesity Medications: Impact on Cardiovascular Risk in Medicare Patients with Obesity

    Jul 1, 2025, 00:00

  • HPR13 Are Commercial Insurance Premiums Associated With the 340B Drug Pricing Program?

    Jul 1, 2025, 00:00

  • RWD118 Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)

    Jul 1, 2025, 00:00

  • MSR56 Comparison of AI-Enhanced Tools for Automating Scientific Literature Reviews

    Jul 1, 2025, 00:00

  • RWD88 Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics

    Jul 1, 2025, 00:00

  • HPR156 The Inflation Reduction Act: Evaluating Impact on Medicare Drug Pricing, Innovation, and Access to Therapies

    Jul 1, 2025, 00:00

  • RWD121 Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study

    Jul 1, 2025, 00:00

  • MSR95 Sizing Up the Gap: Evaluating Sample Size Justification in Prospective Real-World Studies

    Jul 1, 2025, 00:00

  • EE298 Optimized Treatment Sequences for ALK+ Stage IV NSCLC: Cost-Effectiveness Analysis From RCT data and Real-World Evidence

    Jul 1, 2025, 00:00

  • PT39 Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada

    Jul 1, 2025, 00:00

  • HSD105 Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention

    Jul 1, 2025, 00:00

  • MSR41 The Use of Large Language Models for Systematic Literature Review Automation: An Evaluation of Quality and Time Savings

    Jul 1, 2025, 00:00

  • MSR50 Balancing Baseline Characteristics With SMOTE and Propensity Score Weighting in a Comparative Study of PASCAL Transcatheter Valve Repair and Medical Therapy for Degenerative Mitral Regurgitation

    Jul 1, 2025, 00:00

  • RWD47 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia

    Jul 1, 2025, 00:00

  • EE301 Cost-effectiveness Analysis of Zavegepant in Acute Migraine Treatment

    Jul 1, 2025, 00:00

  • EPH141 Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age

    Jul 1, 2025, 00:00

  • EE244 Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO

    Jul 1, 2025, 00:00

  • PCR67 Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling

    Jul 1, 2025, 00:00

  • HSD63 Perspectives on Real-World Management of Stomatitis/Oral Mucositis (S/OM) From Oncologists With Experience Treating Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • EE445 Risk of Hospital Readmission Among Adults Aged 50 Years and Older Hospitalized With Respiratory Syncytial Virus (RSV) or Influenza

    Jul 1, 2025, 00:00

  • EPH176 Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database

    Jul 1, 2025, 00:00

  • MSR27 Barriers to CAR-T Therapy Access in the U.S.: A County-Level Analysis of Proximity and Sociodemographic Factors

    Jul 1, 2025, 00:00

  • EE377 What is the Role of Humans in a World of Artificial Intelligen An Exploratory Economic Evaluation of Human-AI Collaboration in Diabetic Retinopathy Screening

    Jul 1, 2025, 00:00

  • PCR191 Impact Of Valbenazine On Improvements In Health-Related Quality of Life (HRQoL) In Patients With Tardive Dyskinesia (TD): EQ-5D-5L Results From A Phase 4 Randomized Withdrawal Study (NCT03891862)

    Jul 1, 2025, 00:00

  • PCR3 Changes in Functional Status, Work Productivity, and Daily Activities in People With Idiopathic Hypersomnia and Narcolepsy Treated With Low-Sodium Oxybate: Results From the Phase 4 DUET Study

    Jul 1, 2025, 00:00

  • HTA75 The Effectiveness of an Individualized eHealth Application on Glycemic Control in Diabetes Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • RWD105 Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023

    Jul 1, 2025, 00:00

  • P41 Incorporating External Opinion in Survival Extrapolations to Inform Long-Term Survival Projections for Health Technology Assessment

    Jul 1, 2025, 00:00

  • PCR215 Self-Reported Health-Related Quality-of-Life in Adolescent Patients with Complex Chronic Health Conditions from A Longitudinal Registry Study in Los Angeles County

    Jul 1, 2025, 00:00

  • RWD3 The Relationship Between Weight and Disease Severity in Dogs with Chronic Kidney Disease: Results from a Real-World Study

    Jul 1, 2025, 00:00

  • RWD155 Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States

    Jul 1, 2025, 00:00

  • EE429 Economic Burden of HER2+ Breast Cancer and the Targeted Therapies Epidemiological Economic Impact in Trinidad and Tobago

    Jul 1, 2025, 00:00

  • HPR135 Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards

    Jul 1, 2025, 00:00

  • EE466 Budget Impact Analysis of the Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for disease prevention among Colombian Infants

    Jul 1, 2025, 00:00

  • EE386 Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada

    Jul 1, 2025, 00:00

  • EE311 The Equitable Quality-Adjusted Life-Year

    Jul 1, 2025, 00:00

  • MSR123 Standardized Tools for Constructing DAGs - Advancing Causal Inference and Risk Assessment in Pharmaceutical Studies

    Jul 1, 2025, 00:00

  • OP10 The Impact of Research Sessions on Pharmacy Students’ Perceived Understanding in Research Design and Methodology

    Jul 1, 2025, 00:00

  • RWD83 Variation in Provider Reimbursement for Biosimilars and Reference Biologics by Commercial Health Plans

    Jul 1, 2025, 00:00

  • HPR1 Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024

    Jul 1, 2025, 00:00

  • EPH174 Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian Province of Manitoba: A Population-Based Cohort Study 2010-2022

    Jul 1, 2025, 00:00

  • HPR24 Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making

    Jul 1, 2025, 00:00

  • MSR147 Evaluating Imaging Artificial Intelligence (AI) Matching Real-World Digital Twins (rwDTs) Into an External Control Arm (ECA) for MYSTIC: A Phase 3 Clinical Trial in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population

    Jul 1, 2025, 00:00

  • RWD97 Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database

    Jul 1, 2025, 00:00

  • MSR92 The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching

    Jul 1, 2025, 00:00

  • HPR133 Coverage Gaps: Do U.S. Commercial Health Plans Have Concordant Alzheimer's Disease Therapy Testing Policies?

    Jul 1, 2025, 00:00

  • PCR232 Patient's Experience of Ulcerative Colitis: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • PCR160 Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study

    Jul 1, 2025, 00:00

  • P25 HELMET: A Benchmark Dataset for Evaluating Generative AI in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • PCR55 Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users

    Jul 1, 2025, 00:00

  • PCR59 Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature

    Jul 1, 2025, 00:00

  • PT31 Psychometric Testing of the ICECAP-A in Patients With Coeliac Disease: A Comparative Analysis With EQ-5D-5L

    Jul 1, 2025, 00:00

  • RWD161 The Contribution of Lab Results Data Linked to Claims Data in Identifying Chronic Kidney Disease Staging

    Jul 1, 2025, 00:00

  • MSR70 Using Machine Learning to Estimate Perceptions and Future Prescribing Intentions of Health Care Providers: A Novel Application of Integrated Primary and Secondary Data in Understanding HCP Decision-Making

    Jul 1, 2025, 00:00

  • EE312 Absenteeism and Presenteeism Associated With Chronic Conditions in a Canadian Working Population

    Jul 1, 2025, 00:00

  • HTA65 An Overview of Pricing and Reimbursement Frameworks for Medicinal Products in Central and Eastern European (CEE) Countries: Mechanisms, Rules, And Managed Entry Agreements (MEAs)

    Jul 1, 2025, 00:00

  • PCR10 Discontinuation Rates of Once-Weekly GLP-1 Receptor Agonists (GLP-1 RAs) in Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • CO89 Persistence of Infliximab Biosimilar versus Originator in Patients with Crohn's Disease: a Retrospective Cohort Study in China

    Jul 1, 2025, 00:00

  • PCR145 Health-Related Quality of Life and Productivity Losses Across Stages of Breast and Colorectal Cancer

    Jul 1, 2025, 00:00

  • EE484 A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians

    Jul 1, 2025, 00:00

  • EPH68 Mortality trends in Centenarians in Colombia, 2008 - 2022

    Jul 1, 2025, 00:00

  • EPH4 All for One and One for All? Patterns of Familial Influenza Vaccination

    Jul 1, 2025, 00:00

  • Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • MSR31 Using Artificial Intelligence to Predict Patient's Preferences

    Jul 1, 2025, 00:00

  • MSR133 A Comprehensive Review of Real-World Evidence (RWE) Use in Submissions to Canada's Drug Agency (CDA)

    Jul 1, 2025, 00:00

  • PT7 Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival

    Jul 1, 2025, 00:00

  • PCR221 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • MSR9 Using Autonomous Generative AI Agents for Data Extraction from Clinical Study Reports: Accuracy Assessment Against Canada's Drug Agency Reports

    Jul 1, 2025, 00:00

  • MSR5 Translation, Cross-Cultural Adaptation and Psychometric Evaluation of the Yoruba Version of Musculoskeletal Health Questionnaire

    Jul 1, 2025, 00:00

  • MSR120 Estimating Sample Size for Training Ensemble Machine Learning Models

    Jul 1, 2025, 00:00

  • RWD120 Comparison of Demographics and Clinical Characteristics Using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts

    Jul 1, 2025, 00:00

  • HPR55 Assessing the Impact of the United States (US) Inflation Reduction Act (IRA) Regulations on Investment Incentives for Orphan Disease Drug Development

    Jul 1, 2025, 00:00

  • HSD80 Assessing Real-World Dosing Patterns for Vesicular Monoamine Transporter-2 Inhibitors (VMAT2i), Valbenazine and Deutetrabenazine, Among Patients with Tardive Dyskinesia (TD) in a Nationwide US Claims Database

    Jul 1, 2025, 00:00

  • MT4 Exploring Mobile and Wearable Technology for Early Depression Detection and Monitoring

    Jul 1, 2025, 00:00

  • HPR152 Characterizing Social Determinants of Health in the Population Receiving Respiratory Syncytial Virus Vaccination in a Nationwide Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • RWD20 Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials

    Jul 1, 2025, 00:00

  • EE214 Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States

    Jul 1, 2025, 00:00

  • RWD108 A1c Improvement After Initiating Real-Time Continuous Glucose Monitoring Among People with Type 2 Diabetes Not on Insulin Therapy

    Jul 1, 2025, 00:00

  • HSD69 Patient Characteristics and Treatment Patterns in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

    Jul 1, 2025, 00:00

  • MSR72 Integrating Artificial Intelligence (AI) and Machine Learning (ML) Techniques With Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Precision Medicine: A Scoping Review

    Jul 1, 2025, 00:00

  • PCR236 Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States

    Jul 1, 2025, 00:00

  • RWD160 Optimizing Adherence to Intravenous Iron: A Geographic Analysis of Variability Within the United States

    Jul 1, 2025, 00:00

  • RWD79 Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics

    Jul 1, 2025, 00:00

  • MSR20 Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • EPH11 Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study

    Jul 1, 2025, 00:00

  • HPR4 Evolving HTA and Potential EU HTAR Ripple Effects in the US: Insights From a Stakeholder Survey

    Jul 1, 2025, 00:00

  • EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada

    Jul 1, 2025, 00:00

  • EPH127 Assessment of Racial Disparities in Prenatal Flu Vaccination in the United States

    Jul 1, 2025, 00:00

  • MSR105 Stability of a Large Language Model for Data Extraction in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HSD66 Environmental Impact of Digital Remote Care Versus Standard Care for CML Patients

    Jul 1, 2025, 00:00

  • HTA25 Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making

    Jul 1, 2025, 00:00

  • PCR46 The Association Between COVID-19 Vaccination and Health-Related Quality of Life and Work Productivity: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EE475 Description and Healthcare Resource Utilization of Patients With Moderate or Severe Lupus Using US Insurance Claims

    Jul 1, 2025, 00:00

  • HSD30 Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States

    Jul 1, 2025, 00:00

  • MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods

    Jul 1, 2025, 00:00

  • MSR26 Sentence-Level Abstract Section Classification in HEOR Literature using a Biomedical Language Model

    Jul 1, 2025, 00:00

  • RWD119 Identification and mapping of Real-World Data Sources for Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)

    Jul 1, 2025, 00:00

  • HPR165 Application of England's Severity Weighting to Cost-Effectiveness Evaluations in Japan

    Jul 1, 2025, 00:00

  • MSR142 Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors

    Jul 1, 2025, 00:00

  • PCR77 Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • EE268 Cost-Effectiveness Analysis of Mirvetuximab Soravtansine in FRa-Positive Platinum-Resistant Ovarian Cancer in Japan

    Jul 1, 2025, 00:00

  • MSR122 MetaSLR: AI-Driven Screening and Extraction Platform with Integrated Quality Assurance Checkpoints

    Jul 1, 2025, 00:00

  • RWD152 Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • EPH45 Evaluating the National and Regional Prevalence and Incidence Rates of Hepatitis Delta Virus Among Patients With Hepatitis B Virus Infection in Italy

    Jul 1, 2025, 00:00

  • EE495 Economic Impact of Experiential Negative Symptoms Among Patients Living With Schizophrenia: Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • PCR157 Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers

    Jul 1, 2025, 00:00

  • HPR157 Evaluating the Effect of Type of Insurance Coverage on Changes in Prescription Medication Utilization During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • P38 Cost-Effectiveness of Belimumab for the Treatment of Adults With Active Lupus Nephritis in Canada

    Jul 1, 2025, 00:00

  • PCR238 Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency

    Jul 1, 2025, 00:00

  • RWD12 Patient-Reported Symptoms and Quality of Life: A Real-World Survey of Patients With Muscle Invasive Bladder Cancer

    Jul 1, 2025, 00:00

  • HPR118 The Role of Invasive Diagnostics in Prior Authorization for MASH

    Jul 1, 2025, 00:00

  • EE461 Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR163 Inequities in Access to Oncology Drugs in Brazil - the Case of Public and Private Healthcare Systems

    Jul 1, 2025, 00:00

  • EE402 Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States

    Jul 1, 2025, 00:00

  • MT36 Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • P39 Cost-Effectiveness of Transthyretin Stabilizing Agents for the Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Jul 1, 2025, 00:00

  • PCR234 Health-Related Quality of Life in Individuals with Diagnosed Depression, Self-Reported Depression, and Non-Depressed: A Multi-Center Cross-Sectional Study

    Jul 1, 2025, 00:00

  • PCR74 Utility of Mobile Health Applications, Wearable Devices, and Patient Generated Health Data in Menopause Research

    Jul 1, 2025, 00:00

  • HSD41 Impact of Racial and Ethnic Disparities on Health-Related Quality of Life in Older Adults With Arthritis in the United States

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »